Bristol-Myers Squibb buy Truist Financial Co.
Start price
06.10.23
/
50%
€53.50
Target price
06.10.24
€79.27
Performance (%)
-4.00%
Price
04.10.24
€49.16
This prediction will end soon
Summary
This prediction is currently active. With a performance of -4.00%, the BUY prediction by Truist_Financial_Co_ is trending in the wrong direction. Dividends of €2.20 are taken into consideration when calculating the performance. This prediction currently runs until 06.10.24. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Bristol-Myers Squibb | 7.807% | 7.807% |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol-Myers Squibb (NYSE: BMY) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $84.00 price target on the stock.
Ratings data for BMY provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Bristol-Myers Squibb
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€55.60
15.09.23
15.09.23
€78.67
15.09.24
15.09.24
-20.88%
16.09.24
16.09.24